Rita Nanda to Molecular Targeted Therapy
This is a "connection" page, showing publications Rita Nanda has written about Molecular Targeted Therapy.
Connection Strength
0.252
-
Immune Checkpoint Inhibitor Therapy in Breast Cancer. J Natl Compr Canc Netw. 2018 10; 16(10):1259-1268.
Score: 0.141
-
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update. J Clin Oncol. 2021 12 10; 39(35):3938-3958.
Score: 0.043
-
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases. Breast Cancer Res Treat. 2018 Oct; 171(3):637-648.
Score: 0.035
-
First international TNBC conference meeting report. Breast Cancer Res Treat. 2018 Jun; 169(3):407-412.
Score: 0.034